Cardiol Therapeutics (OTCMKTS:CRTPF) Trading Up 2.1% – Here’s Why

Cardiol Therapeutics Inc. (OTCMKTS:CRTPFGet Free Report)’s stock price traded up 2.1% during mid-day trading on Thursday . The company traded as high as $1.95 and last traded at $1.94. 371,750 shares changed hands during trading, an increase of 454% from the average session volume of 67,097 shares. The stock had previously closed at $1.90.

Cardiol Therapeutics Price Performance

The firm has a 50-day moving average price of $2.03 and a 200 day moving average price of $2.08.

Cardiol Therapeutics Company Profile

(Get Free Report)

Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.

See Also

Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.